|
시장보고서
상품코드
2050545
피부 주입제 시장 : 소재별, 용도별, 제품 유형별, 성별, 최종사용자별, 지역별Dermal Fillers Market, By Material Type, By Application, By Product Type, By Gender, By End User, By Geography |
||||||
피부 주입제 시장은 2026년에 57억 2,000만 달러로 추정되고 있으며, 2033년까지 124억 1,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 11.7%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 57억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 11.70% | 2033년 시장 규모 예측 : | 124억 1,000만 달러 |
세계의 피부주사제 시장은 비침습적 미용 시술 및 안티에이징 치료에 대한 소비자 수요 증가를 배경으로 미용의학 산업에서 빠르게 성장하고 있는 분야입니다. 진피 필러는 얼굴이나 신체의 대상 부위의 주름을 메우고, 구조를 정돈하여 볼륨을 회복하고, 주름을 펴고, 얼굴의 윤곽을 아름답게 만드는 것을 목적으로 하는 주사제입니다. 이 의료기기는 주로 히알루론산, 칼슘하이드록시파타이트, PLLA(Poly-L-lactic Acid) 및 기타 일시적 또는 반영구적인 미용 효과를 제공하는 생체적합성 재료로 구성됩니다.
이 시장에는 팔자주름, 팔자주름, 입술 확대술, 볼처짐, 눈밑 꺼짐 등 다양한 치료 부위에 대응하는 다양한 제품들이 포함되어 있습니다. 기술의 발전으로 보다 안전하고 효과적인 제형과 주사 기술이 개발됨에 따라 더 많은 사람들이 더 쉽게 진피 필러를 사용할 수 있게 되었습니다. 가처분 소득의 증가, 미용 시술에 대한 인식의 증가, 소셜미디어의 영향, 외과적 미용 시술의 대안에 대한 저침습적 대안에 대한 수요로 인해 이 산업은 괄목할 만한 성장세를 보이고 있습니다. 피부과 전문의, 성형외과 전문의, 숙련된 미용 시술자를 포함한 의료 전문가들은 혁신적인 치료 프로토콜과 환자 치료 결과 개선을 통해 시장 확대를 주도하고 있습니다.
시장 역학
세계의 피부 주입제 시장은 몇 가지 주요 요인에 의해 주도되고 있으며, 이는 전반적으로 견고한 성장 궤도를 견인하고 있습니다. 주요 요인은 전 세계 고령화 진행에 있으며, 이는 노화 방지 치료 및 미용 시술에 대한 수요 증가와 직접적으로 관련이 있습니다. 소셜미디어 플랫폼과 셀러브리티 문화는 소비자 행동에 큰 영향을 미치고 있으며, 젊은 층의 미용 시술에 대한 인지도와 수용성을 높이고 있습니다. 안전성이 향상되고 효과가 오래 지속되는 제품을 포함한 필러 제제의 기술적 진보로 인해 치료 결과가 개선되고 관련 위험이 감소함에 따라 소비자의 신뢰가 높아지고 있습니다. 특히 신흥 국가의 가처분 소득이 증가함에 따라 이전에는 사치스러운 서비스로 여겨졌던 미용 시술에 대한 접근성이 확대되고 있습니다.
수술적 치료를 대체할 수 있는 최소침습적 시술에 대한 선호도가 높아지면서 시장 확대를 주도하고 있으며, 이는 피부 주입제가 다운타임을 최소화하면서 즉각적인 결과를 제공하기 때문입니다. 그러나 시장은 성장 모멘텀을 저해할 수 있는 뚜렷한 제약에 직면해 있습니다. 엄격한 규제 프레임워크와 신제품에 대한 긴 승인 절차는 시장 진입과 혁신의 장벽이 되고 있습니다. 무자격 시술자 및 위조 제품과 관련된 안전 문제는 심각한 위험을 초래하고 시장 평판과 소비자 신뢰를 훼손할 수 있습니다. 높은 치료비와 보험 적용이 되지 않는 상황은 가격에 민감한 소비자의 접근성을 제한하고 있습니다. 또한 잠재적인 부작용과 합병증은 발생 빈도는 낮지만, 치료를 고려하는 환자들 사이에서 주저하게 만드는 요인이 되고 있습니다. 이러한 도전에도 불구하고 시장 상황에는 큰 기회가 존재합니다. 아시아태평양, 라틴아메리카, 중동의 신흥 시장은 의료 인프라가 잘 갖추어져 있고, 미용에 대한 인식이 높아지면서 미개발된 잠재력을 가지고 있습니다. 지속성과 생체적합성이 개선된 차세대 필러의 개발은 새로운 치료의 가능성을 열어주고 있습니다.
본 조사의 주요 특징.
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 피부 주입제 시장의 주요 기업 개요을 작성합니다. : 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 이 세계의 피부 주입제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 피부주사제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 피부 주입제 시장 : 소재 유형별, 2021-2033년
제5장 세계의 피부 주입제 시장 : 용도별, 2021-2033년
제6장 세계의 피부 주입제 시장 : 제품 유형별, 2021-2033년
제7장 세계의 피부 주입제 시장 : 성별, 2021-2033년
제8장 세계의 피부 주입제 시장 : 최종사용자별, 2021-2033년
제9장 세계의 피부 주입제 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KSA 26.06.10Dermal Fillers Market is estimated to be valued at USD 5.72 Bn in 2026 and is expected to reach USD 12.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.72 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.70% | 2033 Value Projection: | USD 12.41 Bn |
The global dermal fillers market represents a rapidly expanding segment within the aesthetic medicine industry, driven by increasing consumer demand for non-invasive cosmetic procedures and age-defying treatments. Dermal fillers are injectable substances designed to restore volume, smooth wrinkles, and enhance facial contours by filling in lines and adding structure to targeted areas of the face and body. These medical devices primarily consist of hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid, and other biocompatible materials that provide temporary to semi-permanent aesthetic improvements.
The market encompasses a diverse range of products catering to various treatment areas including nasolabial folds, marionette lines, lip augmentation, cheek enhancement, and under-eye hollows. With technological advancements leading to safer, more effective formulations and improved injection techniques, dermal fillers have become increasingly accessible to a broader demographic. The industry has witnessed significant growth due to rising disposable incomes, growing awareness about aesthetic procedures, social media influence, and the desire for minimally invasive alternatives to surgical cosmetic procedures. Healthcare professionals, including dermatologists, plastic surgeons, and trained aesthetic practitioners, continue to drive market expansion through innovative treatment protocols and enhanced patient outcomes.
Market Dynamics
The global dermal fillers market is propelled by several key drivers that collectively fuel its robust growth trajectory. The primary driver stems from the increasing aging population worldwide, which directly correlates with higher demand for anti-aging treatments and aesthetic procedures. Social media platforms and celebrity culture significantly influence consumer behavior, creating heightened awareness and acceptance of cosmetic procedures among younger demographics. Technological advancements in filler formulations, including longer-lasting products with improved safety profiles, have enhanced treatment outcomes and reduced associated risks, thereby boosting consumer confidence. Rising disposable incomes, particularly in emerging economies, enable broader access to aesthetic treatments previously considered luxury services.
The growing preference for minimally invasive procedures over surgical alternatives drives market expansion, as dermal fillers offer immediate results with minimal downtime. However, the market faces notable restraints that could impede growth momentum. Stringent regulatory frameworks and lengthy approval processes for new products create barriers to market entry and innovation. Safety concerns related to unqualified practitioners and counterfeit products pose significant risks, potentially damaging market reputation and consumer trust. High treatment costs and lack of insurance coverage limit accessibility for price-sensitive consumers. Additionally, potential side effects and complications, though rare, create hesitancy among prospective patients. Despite these challenges, substantial opportunities exist within the market landscape. Emerging markets in Asia-Pacific, Latin America, and the Middle East present untapped potential due to increasing healthcare infrastructure and growing aesthetic awareness. The development of next-generation fillers with enhanced longevity and biocompatibility opens new treatment possibilities.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global dermal fillers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Allergan (AbbVie), Revance Therapeutics, Inc., Ipsen, Merz Pharmaceuticals, Medytox, Inc., Galderma, Hugel, Inc., Anika Therapeutics, Inc., Bioxis Pharmaceuticals, Prollenium Medical Technologies, Sinclair Pharma, LG Chem, TEOXANE, RHA Collection (Revance Therapeutics), and Carefill.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global dermal fillers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermal fillers market.
Market Segmentation
- Material Type Insights (Revenue, USD Bn, 2021 - 2033)
- Hyaluronic Acid
- Calcium Hydroxylapatite
- Poly-L-lactic Acid
- Polymethylmethacrylate
- Fat Fillers (Autologous Fat Transfer)
- Others (Collagen)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Facial Wrinkle Treatment
- Volume Loss Treatment
- Facial Contouring
- Lip Enhancement
- Scar Treatment
- Other Cosmetic Applications
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Biodegradable/Absorbable Fillers
- Non-Biodegradable Fillers
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Female
- Male
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Cosmetic Clinics
- Dermatology Clinics
- Hospitals
- Homecare Settings
- Others (Medical Spa)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Allergan (AbbVie)
- Revance Therapeutics, Inc.
- Ipsen
- Merz Pharmaceuticals
- Medytox, Inc.
- Galderma
- Hugel, Inc.
- Anika Therapeutics, Inc.
- Bioxis Pharmaceuticals
- Prollenium Medical Technologies
- Sinclair Pharma
- LG Chem
- TEOXANE
- RHA Collection (Revance Therapeutics)
- Carefill
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Dermal Fillers Market, By Material Type
- Global Dermal Fillers Market, By Application
- Global Dermal Fillers Market, By Product Type
- Global Dermal Fillers Market, By Gender
- Global Dermal Fillers Market, By End User
- Global Dermal Fillers Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Dermal Fillers Market, By Material Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hyaluronic Acid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Calcium Hydroxylapatite
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Poly-L-lactic Acid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Polymethylmethacrylate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fat Fillers (Autologous Fat Transfer)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Collagen)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Dermal Fillers Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Facial Wrinkle Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Volume Loss Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Facial Contouring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lip Enhancement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Scar Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Cosmetic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Dermal Fillers Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biodegradable/Absorbable Fillers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non-Biodegradable Fillers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Dermal Fillers Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Dermal Fillers Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cosmetic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dermatology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Medical Spa)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Dermal Fillers Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Material Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive landscape
- Allergan (AbbVie)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Revance Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ipsen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merz Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medytox, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Galderma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hugel, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Anika Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioxis Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Prollenium Medical Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sinclair Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LG Chem
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- TEOXANE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- RHA Collection (Revance Therapeutics)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Carefill
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
